... of CE Mark trials for both HeartMate III and HeartMate PHP, while HeartMate III also received conditional approval from FDA to begin the U.S. trial.
more
more
Home »Unlabelled » Thoratec Shares Plummet 26% As 2014 Outlook Slashed, Q2 Profit Declines
Posted by Unknown on Wednesday, August 6, 2014
2010 All Rights Reserved Php programming tips.
» Php programming tips: Thoratec Shares Plummet 26% As 2014 Outlook Slashed, Q2 Profit Declines
{ 0 comments... » Thoratec Shares Plummet 26% As 2014 Outlook Slashed, Q2 Profit Declines read them below or add one }
Post a Comment